Diabetes Metab Syndr Obes 16:24332446 Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V et al (2023) Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
Le Couteur, Maria Nicola Gadaleta, Giuseppe Castello, and Giovanni Pagano
See Figure 1
The licensed medications for weight management include GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda)
B12 plays a role in normal energy metabolism and may help support you on your weight and wellness journey
We thank our Data and Safety Monitoring Committee, our TSC and Trial Management Group members, and our patient and public involvement and engagement representatives who reviewed the trial protocol and participated in our TSC and Monitoring Committees